Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemosensitization by monofunctional alkylating agents.

J M Walling, I J Stratford

    International Journal of Radiation Oncology, Biology, Physics
    |August 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Emerging opportunities for the combination of molecularly targeted drugs with radiotherapy.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2014
    Same author

    Electron-affinic sensitization VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers. 1976.

    Radiation research·2012
    Same author

    Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers.

    British journal of cancer·2011
    Same author

    The hypoxia-selective cytotoxin NLCQ-1 (NSC 709257) controls metastatic disease when used as an adjuvant to radiotherapy.

    British journal of cancer·2010
    Same author

    Guidelines for the welfare and use of animals in cancer research.

    British journal of cancer·2010
    Same author

    Radiotherapy research priorities for the UK.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2010
    Same journal

    Single Percussive Ventilation Breath-hold Imaging and Delivery in Lung Tumor Stereotactic Ablative Radiation Therapy: Initial Observations From a Prospective Clinical Trial.

    International journal of radiation oncology, biology, physics·2026
    Same journal

    Proton beam therapy in nonmetastatic rhabdomyosarcoma: Outcome, prognostic factors and the effect of timing of radiation therapy.

    International journal of radiation oncology, biology, physics·2026
    Same journal

    Hypofractionated Proton Reirradiation for Recurrent Glioblastoma: Clinical and Dosimetric Outcomes from a Large Single Institution Series.

    International journal of radiation oncology, biology, physics·2026
    Same journal

    Gastrointestinal Motility-Induced Interplay in Pancreas Proton Therapy: Motion Simulation and Dosimetric Impact.

    International journal of radiation oncology, biology, physics·2026
    Same journal

    Intra-fractional Voxel-wise Anatomical Motion Tracking Guided by Multimodal Respiratory Surrogates in Radiotherapy: Framework Development and Multi-Center Validation.

    International journal of radiation oncology, biology, physics·2026
    Same journal

    A Gaussian-based planning approach for robust dose-escalated stereotactic body proton therapy.

    International journal of radiation oncology, biology, physics·2026
    See all related articles

    Alkyl sulfonates like methyl methanesulfonate (MMS) and ethyl methanesulfonate (EMS) enhance chemotherapy sensitivity in V79 cells, unlike N-methyl-N-nitrosoguanidine (MNNG). This suggests these agents impact initial DNA alkylation, improving drug efficacy.

    Area of Science:

    • Molecular Biology
    • Cancer Research
    • Pharmacology

    Background:

    • Chemosensitization is crucial for enhancing cancer therapy efficacy.
    • Monofunctional alkylating agents exhibit varying DNA base alkylating characteristics.
    • Understanding agent-specific effects is key to optimizing treatment strategies.

    Purpose of the Study:

    • To investigate the chemosensitizing potential of methyl methanesulfonate (MMS), ethyl methanesulfonate (EMS), and N-methyl-N-nitrosoguanidine (MNNG).
    • To determine if these agents sensitize V79 cells to cisplatin and melphalan.
    • To elucidate the mechanism underlying the observed chemosensitization.

    Main Methods:

    • Exposure of V79 cells to MMS, EMS, and MNNG.
    • Assessment of chemosensitization to cisplatin and melphalan.

    Related Experiment Videos

  • Analysis of dose-response curves and drug scheduling experiments.
  • Evaluation of thiourea post-treatment effects.

    • Main Results:

    • Methyl methanesulfonate (MMS) and ethyl methanesulfonate (EMS) demonstrated chemosensitizing effects on V79 cells treated with cisplatin and melphalan.
    • N-methyl-N-nitrosoguanidine (MNNG) did not exhibit chemosensitizing properties.
    • Dose-response curves showed shoulder removal, indicating enhanced cell killing.
    • Drug scheduling and thiourea experiments suggested the mechanism involves initial DNA alkylation rather than crosslink formation.

    Conclusions:

    • Alkyl sulfonates (MMS, EMS) can chemosensitize V79 cells to standard chemotherapeutic agents.
    • The chemosensitizing effect appears to be mediated by influencing the initial DNA alkylation step.
    • MNNG's lack of chemosensitization highlights agent-specific mechanisms in DNA damage response.